Ep 67: AI and delusions of beauty, with Gretc...

Responsible AI is a much vaunted concept that aims to connect AI with human rights, equality and fairness. Whocould argue with that? Well there are plenty of critics who complain that in practice, restrictions of these kind only stifle innovation and progress. And in accepting su ...  Show more

Agentic AI systems are causing a huge buzz right now. These are AI systems that actively make changes in the world as opposed to merely giving information. In healthcare, could agentic AI systems help address the huge problem of preventable disease ? This is an economic drain tha ...  Show more

Why is the process of creating a new and highly beneficial pharmaceutical drug so difficult? What are the hurdles researchers face when trying to identify a new drug? Why are side effects so challenging to predict? Why are pharmaceutical drugs so expensive? In today's episode, we ...  Show more

It may seem intuitive that AI and deep learning can speed up workflows — including novel drug discovery, a typically years-long and several-billion-dollar endeavor. But professors Artem Cherkasov and Olexandr Isayev were surprised to find that no recent academic papers provided a ...  Show more

According to the CDC, 6 in 10 adults in the U.S. have a chronic disease like cancer or diabetes. Meanwhile, the process for discovering new drug treatments is critically expensive and inefficient. About 90% of drug candidates fail to gain FDA approval; the average cost to develop ...  Show more

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ...  Show more